Commodore Capital LP → Editas Medicine, Inc. EDIT

Stake: — Shares: — Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 8.02

22,197,638 shares short · -1.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $1.50M

Point72 Asset Mgmt

Other 13D/G Filings on Editas Medicine, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-03	SCHEDULE 13G	TCG Crossover GP III, LLC	—	—	view →
2026-06-03	SCHEDULE 13G	RA CAPITAL MANAGEMENT, L.P.	—	—	view →

Other Filings by Commodore Capital LP

Filed	Form	Issuer	Stake	Shares
2026-07-20	SCHEDULE 13G	Research Alliance Corp IV	—	—	view →
2026-06-18	SCHEDULE 13G	Avalo Therapeutics, Inc. AVTX	—	—	view →
2026-06-03	SCHEDULE 13G	EyePoint, Inc. EYPT	—	—	view →
2026-05-28	SCHEDULE 13G	Research Alliance Corp III RACC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →